Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-20

Clinical Trial Update: Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial updates safety and efficacy of IDP-118 Lotion compared with Ultravate for plaque psoriasis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IDP-118 Lotion (IDP-118 lotion)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-20